代谢疾病A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.
期刊:Diabetologia发表年份:2013作者:V K Bhat; B D Kerr; S Vasu; P R Flatt; V A Gault
追踪行业前沿,洞察产业趋势